Middle East IPO market set to continue growing in 2024
Initial public offerings in the Middle East are poised for continued positive aftermarket performance this year, following significant post-IPO gains in
Stay updated with breaking news from Avalon Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Initial public offerings in the Middle East are poised for continued positive aftermarket performance this year, following significant post-IPO gains in
Middle East Pharmaceutical Industries Company’s (Avalon Pharma) initial public offering (IPO) has netted SR2.67 billion ($712.1 million) in retail subscription indicating an oversubscription of 54.3 times.
December saw PureHealth's mega IPO; now, Saudi Avalon Pharma gets its share of investors
Doha, Qatar: According to the EY MENA IPO Eye Q4 2023 report, MENA markets saw 48 initial public offerings (IPOs) in 2023,raising $10.7b in total. Fiv...
Middle East Pharmaceutical Industries Company’s (Avalon Pharma) initial public